Skip to main content

Bosulif Copay Card

Pfizer

UnknownUnder review·Apr 24, 2026

The Bosulif Co-Pay Card is a financial assistance program provided by Pfizer for eligible, commercially insured patients taking BOSULIF (bosutinib). It helps patients pay as little as $0 a month for their prescription, with a maximum benefit of $9,450 per use. To qualify, patients must be 18 or older, live in the US or Puerto Rico, have private commercial insurance, and not be enrolled in federal or state prescription drug programs like Medicare or Medicaid, nor be cash-paying.

Covers
financial assistance
Max award
$9,450
Enrollment cycle
unknown

Eligibility

Patients must be 18 years or older, reside in the U.S. or Puerto Rico, and possess private commercial insurance. Those enrolled in federal or state-funded prescription drug programs like Medicare or Medicaid are ineligible.

Apply

Application goes directly to Pfizer. RxCopays does not receive compensation.

Go to application →

Rare-disease support beyond financial help

This grant covers a rare condition. For specialists, clinical trials, and patient communities, our sister site UniteRare.org has in-depth pages: